Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute
Antoni, G.; Arezzini, C.; Cocola, F.; Gazzei, G.; Neri, P.
Il Farmaco; Edizione Pratica 34(4): 146-156
1979
ISSN/ISBN: 0430-0912 PMID: 456552 Document Number: 150640
Document emailed within 1 workday
Related Documents
Von Bormann, B.; Hempelmann, G. 1985: Evaluation of the colloidal plasma substitute 6% HES 40/0,5 Der Anaesthesist 34(5): 265-266Borodaĭ, E.I.; Senik, I.K.; Averbukh, Z.D.; Bilynskiĭ, B.T.; Rozhankivska, L.V. 1973: Evaluation of the viability of twice-washed erythrocytes suspended in a plasma-substitute solution with albumin Problemy Gematologii i Perelivaniia Krovi 18(8): 22-25
Lorenz, W.; Doenicke, A.; Freund, M.; Schmal, A.; Dormann, P.; Praetorius, B.; Schürk-Bulich, M. 1975: Plasma histamine levels in man following infusion of hydroxyethyl starch: a contribution to the question of allergic or anaphylactoid reactions following administration of a new plasma substitute Der Anaesthesist 24(5): 228-230
Craciunescu, D.G.; Scarcia, V.; Furlani, A.; Papaioannou, A.; Parrondo Iglesias, E.; Alonso, M.P. 1991: Pharmacological and toxicological studies on new Rh(I) organometallic complexes In Vivo 5(4): 329-332
Naik, S.R.; Jalit, R.N.; Raman, P.H.; Karnick, A.K.; Gopalkrishnan, K.S.; Nalini, I.; Thorat, S.L. 1981: Some pharmacological and toxicological effects of JA-20, a new polyene macrolide Hindustan Antibiotics Bulletin 23: 6-11
De la Fuente, R.; Santos, M. 1980: Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) Archivos de Farmacologia y Toxicologia 6(3): 255-264
Propker, M.; Pongracz, M.J.; Szabo, J.L. 1976: Pharmacological and toxicological studies with 1-benzyl-3-(2,3-dihydroxypropoxy)indazole Arzneimittel-Forschung 26(7): 1393-1397
Marquardt, G.M.; Distefano, V.; Ling, L.L. 1978: Pharmacological and toxicological effects of beta-3,4-methylenedioxyamphetamine isomers Toxicology and Applied Pharmacology 45(3): 675-683
Friehe, H.; Ney, P. 1997: Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride Arzneimittel-Forschung 47(2): 132-144
Forbes, L.S. 1972: Toxicological and pharmacological relations between levamisole, pyrantel and diethylcarbamazine and their significance in helminth chemotherapy Southeast Asian Journal of Tropical Medicine and Public Health 3(2): 235-241
Morán Pinto, O. 1972: Use of Haemaccel, new plasma substitute in the treatment of shock Revista Espanola de Anestesiologia y Reanimacion 19(3): 261-262
Muller, M.; Gardi, A.; Straub, R.; Gerber, H. 1978: Use of a gelatin plasma substitute (Physiogel SRK) in the horse Schweizer Archiv für Tierheilkunde 120(10): 501-512
Fanelli, O. 1973: Pharmacological and toxicological study of a new psychotropic stimulant: the 2-phenyl-5-dimethyl-tetrahydro-1,4-oxazine, in comparison with d,l-amphetamine, phenmetrazine and pemoline-Mg Arzneimittel-Forschung 23(6): 810-816
1994: Plasma substitute may improve calcium levels, clot formation Oncology 8(9): 110
Schildt, B.; Bouveng, R.; Sollenberg, M. 1975: Plasma substitute induced impairment of the reticuloendothelial system function Acta Chirurgica Scandinavica 141(1): 7-13
Vanevskiĭ, V.L.; Rimerman, V.E.; Nikonov, N.N.; Khomutova, I.A. 1972: Plasma-substitute crystalloid Ringer-lactate solution in surgical practice Vestnik Khirurgii Imeni I. I. Grekova 108(5): 98-102
Timoshenko, L.V.; Khimenko, M.V. 1985: Use of the bifunctional plasma substitute polyfer to replenish blood loss during labor Akusherstvo i Ginekologiia 1: 35-37
May, B.; Helmstaedt, D. 1975: Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 50-56
Homann, B.; Pesold, R.; Bülow, H.; Rietbrock, I.; Hess, J.; Weis, K.H. 1977: Hydroxy-ethyl-starch as plasma substitute in transurethral prostatectomy with the "cold-punch" method Der Anaesthesist 26(1): 5-10
Pagella, P.G.; Bellavite, O.; Agozzino, S.; Donà, G.C. 1984: Pharmacological and toxicological studies on an iron succinyl-protein complex (ITF282) for oral treatment of iron deficiency anemia Arzneimittel-Forschung 34(9): 952-958